Skip to main content
. 2010 Sep 30;51(6):808–822. doi: 10.3349/ymj.2010.51.6.808

Fig. 4.

Fig. 4

Proteases and PAR-2 in the pathogenesis of atopic dermatitis. LETKI, lympho-epithelial Kazal-type-related inhibitor; PAR-2, protease-activated receptor-2; SCCE, stratum corneum chymotrypsin-like enzyme; SCTE, stratum corneum trypsin-like enzyme; SNP, single nucleotide polymorphism.